 0 Table of Contents |
  1 Home |
  2 Changes |
  3 Copyrights |
  4 Data Types Defined in This Guide |
  5 Design Conventions |
  6 Downloads |
  7 Examples |
  8 General Principles |
  9 Generation and Data Inclusion |
  10 Known Issues and Future Development |
  11 Privacy and Security Considerations |
  12 Profiles |
  13 Structure of the International Patient Summary |
  14 Terminology |
  15 Artifacts Summary |
   15.1 Consumer (IPS) |
   15.2 Producer (IPS) |
   15.3 IPS Server Capability Statement |
   15.4 IPS Summary |
   15.5 AllergyIntolerance (IPS) |
   15.6 Bundle (IPS) |
   15.7 Composition (IPS) |
   15.8 Condition (IPS) |
   15.9 Device (IPS) |
   15.10 Device - Performer or Observer (IPS) |
   15.11 DeviceUseStatement (IPS) |
   15.12 DiagnosticReport (IPS) |
   15.13 Flag - Alert (IPS) |
   15.14 ImagingStudy (IPS) |
   15.15 Immunization (IPS) |
   15.16 Medication (IPS) |
   15.17 MedicationRequest (IPS) |
   15.18 MedicationStatement (IPS) |
   15.19 Observation Pregnancy - Expected Delivery Date (IPS) |
   15.20 Observation Pregnancy - Outcome (IPS) |
   15.21 Observation Pregnancy - Status (IPS) |
   15.22 Observation Results - Laboratory/Pathology (IPS) |
   15.23 Observation Results - Radiology (IPS) |
   15.24 Observation Social History - Alcohol Use (IPS) |
   15.25 Observation Social History - Tobacco Use (IPS) |
   15.26 Organization (IPS) |
   15.27 Patient (IPS) |
   15.28 Practitioner (IPS) |
   15.29 PractitionerRole (IPS) |
   15.30 Procedure (IPS) |
   15.31 Specimen (IPS) |
   15.32 Codeable Concept (IPS) |
   15.33 Coding with translations |
   15.34 Quantity (IPS) |
   15.35 Range (IPS) |
   15.36 Ratio (IPS) |
   15.37 SimpleQuantity (IPS) |
   15.38 Allergies & Intolerances - IPS |
   15.39 Allergy Reaction - IPS |
   15.40 Body Site - IPS |
   15.41 Current Smoking Status - IPS |
   15.42 Diagnostics Report Status Codes - IPS |
   15.43 Healthcare Professional Roles - IPS |
   15.44 Imaging Study Status Codes - IPS |
   15.45 Medical Devices - IPS |
   15.46 Medications - example (IPS) |
   15.47 Medications - IPS |
   15.48 Medicine Active Substances - IPS |
   15.49 Medicine Doseform - IPS |
   15.50 Medicine Route of Administration - IPS |
   15.51 Personal Relationship - IPS [Deprecated] |
   15.52 Pregnancy Expected Delivery Date Method - IPS |
   15.53 Pregnancy Outcome - IPS |
   15.54 Pregnancy Status - IPS |
   15.55 Problem Type (LOINC) |
   15.56 Problem Type - IPS |
   15.57 Problems - IPS |
   15.58 Procedures - IPS |
   15.59 Results Coded Values Laboratory/Pathology - IPS |
   15.60 Results Laboratory/Pathology Observation - IPS |
   15.61 Results Radiology Measurement Observation - IPS |
   15.62 Results Radiology Observation - IPS |
   15.63 Results Radiology Textual Observation - IPS |
   15.64 Results Specimen Collection Method - IPS |
   15.65 Results Specimen Type - IPS |
   15.66 Results Status Codes - IPS |
   15.67 Vaccine Target Diseases - IPS |
   15.68 Vaccines - IPS |
   15.69 Vaccines WHO ATC - IPS |
   15.70 WHO ATC - IPS |
   15.71 AllergyIntolerance - Multiple Codings |
   15.72 AllergyIntolerance - No Known Allergies |
   15.73 AllergyIntolerance - Resolved Allergy |
   15.74 Bundle - IPS with Data |
   15.75 Bundle - IPS with Required Sections and Immunization |
   15.76 Bundle - Minimal Complete IPS |
   15.77 Bundle - No Information in Required Sections |
   15.78 Composition - Minimal Sections |
   15.79 Condition - Acute Myeloid Leukemia |
   15.80 Device - Device Observer |
   15.81 Device - No Known Devices in Use |
   15.82 DeviceUseStatement - No Known Devices in Use |
   15.83 DiagnosticReport - Hemoglobin |
   15.84 Flag - Alert of Patient Immunocompromised |
   15.85 ImagingStudy - Referred DICOM Study |
   15.86 Immunization - Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite (Luxembourg) |
   15.87 Medication - Simvastatin 40 MG Disintegrating Oral Tablet |
   15.88 MedicationRequest - Simvastatin Request |
   15.89 MedicationStatement - Ongoing Simvastatin Treatment |
   15.90 Observation - Social History Alcohol Use |
   15.91 Observation: estrogen receptor in tissue example |
   15.92 Observation: hemoglobin example |
   15.93 Observation: imaging Chest X-ray - PA and lateral, with additional sub-observation including numeric range |
   15.94 Observation: imaging CT Abdomen W contrast IV |
   15.95 Observation: imaging CT Abdomen W contrast IV, sub-observations |
   15.96 Observation: pregnancy edd example |
   15.97 Observation: pregnancy outcome example |
   15.98 Observation: pregnancy status example |
   15.99 Observation: serum creatinine example |
   15.100 Observation: SH tobacco use example |
   15.101 Observation: urine wbc range example |
   15.102 Organization - Minimal Name Only |
   15.103 Organization: example |
   15.104 Organization: lab example |
   15.105 Patient: female patient |
   15.106 Patient: male patient |
   15.107 Patient: minimal example |
   15.108 Practitioner example |
   15.109 PractitionerRole - Minimal |
   15.110 Procedure: Surgical procedure |
   15.111 Specimen: example |